Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Which Coins Are Blue Chip Crypto
This intro covers which coins are blue chip crypto and why they’re favored by investors. We outline criteria, track records, and what to watch before investing.
21,488 articles
Beyond Headlines: Financial Sector Value Prospects 2026
As investors pivot away from high-flying tech, the financial sector could offer underappreciated value. This guide ex...
Retirees Rely These Safe High-Yield Monthly Stocks
As markets stay choppy in early 2026, retirees turn to monthly dividend stocks for predictable income and capital pre...
Netflix Stock Down Nearly From All-Time High: Is It Cheap?
Netflix shares have pulled back from their peak, leaving many investors wondering if the dip represents a buying oppo...
This Medicare Mistake Can Devastate Unprepared Retirees
Healthcare costs loom large in retirement, but a single Medicare misunderstanding can derail finances. This guide exp...
Will Qualify Social Security's Biggest Paycheck in 2026?
Curious if you can win the lottery of Social Security—that $5,251-a-month top payout in 2026? It hinges on work credi...
Cogent (CCOI) 2025 Earnings: Outlook for Investors
Cogent’s Q4 2025 results show steady growth with improving margins and cautious guidance for 2026. This article inter...
Palantir Landed Next Billion: What It Means for Investors
A major government contract marks a turning point for Palantir. This analysis explains how the DHS deal could reshape...
Here's Wouldn't Touch Canopy: Why I Pass in 2026 and Beyond
Cannabis stocks remain volatile and Canopy Growth sits at a crossroads in 2026. This article explains why many invest...
This "magnificent Seven" Stock Down 22%: Buy Before Breakout
One member of the famous seven has slipped 22% from its high. This article outlines whether the drop is a buying sign...
Hedge Funds Offer Locked-Up Investors Sudden Exit Options
Two private-credit funds unveiled exit options for locked-up investors, offering steep discounts and renewed liquidit...
Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status